194 related articles for article (PubMed ID: 25839418)
1. Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina.
Gilabert-Oriol R; Weng A; von Mallinckrodt B; Stöshel A; Nissi L; Melzig MF; Fuchs H; Thakur M
Int J Pharm; 2015 Jun; 487(1-2):39-48. PubMed ID: 25839418
[TBL] [Abstract][Full Text] [Related]
2. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
[TBL] [Abstract][Full Text] [Related]
3. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
[TBL] [Abstract][Full Text] [Related]
4. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
5. Foamy matters: an update on
Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
[TBL] [Abstract][Full Text] [Related]
6. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
Kensil CR; Patel U; Lennick M; Marciani D
J Immunol; 1991 Jan; 146(2):431-7. PubMed ID: 1987271
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria.
Nyberg NT; Baumann H; Kenne L
Anal Chem; 2003 Jan; 75(2):268-74. PubMed ID: 12553761
[TBL] [Abstract][Full Text] [Related]
8. Saponins from
Fleck JD; Betti AH; da Silva FP; Troian EA; Olivaro C; Ferreira F; Verza SG
Molecules; 2019 Jan; 24(1):. PubMed ID: 30621160
[No Abstract] [Full Text] [Related]
9. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
[TBL] [Abstract][Full Text] [Related]
10. Isolation and evaluation of immunological adjuvant activities of saponins from Polygala senega L.
Estrada A; Katselis GS; Laarveld B; Barl B
Comp Immunol Microbiol Infect Dis; 2000 Jan; 23(1):27-43. PubMed ID: 10660256
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A.
Kamstrup S; San Martin R; Doberti A; Grande H; Dalsgaard K
Vaccine; 2000 Apr; 18(21):2244-9. PubMed ID: 10717344
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.
Fleck JD; Kauffmann C; Spilki F; Lencina CL; Roehe PM; Gosmann G
Vaccine; 2006 Nov; 24(49-50):7129-34. PubMed ID: 16887242
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
Rönnberg B; Fekadu M; Morein B
Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
[TBL] [Abstract][Full Text] [Related]
14. Quillaja Saponin Characteristics and Functional Properties.
Reichert CL; Salminen H; Weiss J
Annu Rev Food Sci Technol; 2019 Mar; 10():43-73. PubMed ID: 30664381
[TBL] [Abstract][Full Text] [Related]
15. A liquid chromatography coupled to quadrupole-time-of-flight-mass spectrometry (LC-QTOF-MS) method for identification analysis of saponins from Quillaja saponaria bark extracts in foot-and-mouth disease vaccines: Development, validation and applicability.
de Andrade DF; Jank L; Rego VB; Minozzo R; Sfoggia MVB; Bavaresco Á; Barreto F
Biomed Chromatogr; 2020 Sep; 34(9):e4873. PubMed ID: 32367529
[TBL] [Abstract][Full Text] [Related]
16. Structural characterisation of new immunoadjuvant saponins from leaves and the first study of saponins from the bark of Quillaja brasiliensis by liquid chromatography electrospray ionisation ion trap mass spectrometry.
Wallace F; Bennadji Z; Ferreira F; Olivaro C
Phytochem Anal; 2019 Nov; 30(6):644-652. PubMed ID: 31059191
[TBL] [Abstract][Full Text] [Related]
17. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
[TBL] [Abstract][Full Text] [Related]
18. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines.
Dalsgaard K
Arch Gesamte Virusforsch; 1974; 44(3):243-54. PubMed ID: 4365900
[No Abstract] [Full Text] [Related]
19. Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant hepatitis B surface antigen.
So HS; Yoon HS; Choi DY; Kwon YS; Sung JH; Lee TG; Park ES; Cho HS; Lee BM; Cho JM; Ryu WS
Mol Cells; 1997 Apr; 7(2):178-86. PubMed ID: 9163729
[TBL] [Abstract][Full Text] [Related]
20. IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice.
Cibulski S; Teixeira TF; Varela APM; de Lima MF; Casanova G; Nascimento YM; Fechine Tavares J; da Silva MS; Sesterheim P; Souza DO; Roehe PM; Silveira F
Vaccine; 2021 Jan; 39(3):571-579. PubMed ID: 33339669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
